Elevation Spine has obtained US Food and Drug Administration (FDA) clearance for Saber-XA, an anterior lumbar interbody fusion (ALIF) system with an expandable cage for degenerative disc disease treatment and spinal column stabilisation.

Elevation highlighted that due to Saber-XA’s form factor, surgeons can independently adjust the implant’s height angle based on individual patient anatomy.

FDA clearance for Saber-XA comes weeks after the California-based company secured FDA clearance for Saber-C AVIA, a cervical fixation device to treat spinal pathologies including nerve compression by stabilising the vertebrae, damaged disc replacements, and to promote bone fusion.